Ovid Therapeutics enters consulting agreement with departing General Counsel Thomas Perone

Ovid Therapeutics Inc.

Thomas Perone departed as General Counsel, CCO and Corporate Secretary effective July 11, 2024, as part of a workforce reduction.
Consulting agreement effective July 11, 2024 through January 31, 2025 to transition duties.
Perone eligible for monthly consulting fee totaling up to $55,000 over the consulting period.
Outstanding equity awards will continue to vest during the consulting period.
Consulting agreement includes post-termination non-solicitation covenants through one year after termination.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Thomas Perone

General Counsel, Chief Compliance Officer and Corporate Secretary

OVID · Ovid Therapeutics Inc.

Effective: 2024-07-11
Filed: August 2, 2024, 7:59 PM ET

On June 27, 2024, Ovid Therapeutics Inc. (the “Company”) announced that Thomas Perone, the Company’s former General Counsel, Chief Compliance Officer and Corporate Secretary, would be departing from the Company in those roles, effective as of July 11, 2024 (the “Separation Date”) in connection with a workforce reduction.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Perone departed as General Counsel, Chief Compliance Officer and Corporate Secretary at Ovid Therapeutics Inc..

Action: departed
Role: General Counsel, Chief Compliance Officer and Corporate Secretary

Exact text from the filing

On June 27, 2024, Ovid Therapeutics Inc. (the “Company”) announced that Thomas Perone, the Company’s former General Counsel, Chief Compliance Officer and Corporate Secretary, would be departing from the Company in those roles, effective as of July 11, 2024 (the “Separation Date”) in connection with a workforce reduction.

View on SEC.gov

Ovid Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-034481

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.